丝状病毒感染的免疫相关性。
Correlates of immunity to filovirus infection.
机构信息
United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland, MD 21702, USA.
出版信息
Viruses. 2011 Jul;3(7):982-1000. doi: 10.3390/v3070982. Epub 2011 Jun 27.
Abstract
Filoviruses can cause severe, often fatal hemorrhagic fever in humans. Recent advances in vaccine and therapeutic drug development have provided encouraging data concerning treatment of these infections. However, relatively little is known about immune responses in fatal versus non-fatal filovirus infection. This review summarizes the published literature on correlates of immunity to filovirus infection, and highlights deficiencies in our knowledge on this topic. It is likely that there are several types of successful immune responses, depending on the type of filovirus, and the presence and timing of vaccination or drug treatment.
摘要
丝状病毒可引起人类严重的、常致命的出血热。疫苗和治疗药物研发的最新进展为这些感染的治疗提供了令人鼓舞的数据。然而，对于致命性与非致命性丝状病毒感染中的免疫反应，人们知之甚少。本综述总结了有关丝状病毒感染免疫相关性的已发表文献，并强调了我们在这一主题上知识的不足。根据丝状病毒的类型、疫苗接种或药物治疗的存在和时机，很可能存在几种类型的成功免疫反应。
相似文献
1
Correlates of immunity to filovirus infection.丝状病毒感染的免疫相关性。
Viruses. 2011 Jul;3(7):982-1000. doi: 10.3390/v3070982. Epub 2011 Jun 27.
2
The Role of Cytokines and Chemokines in Filovirus Infection.细胞因子和趋化因子在丝状病毒感染中的作用
Viruses. 2015 Oct 23;7(10):5489-507. doi: 10.3390/v7102892.
3
Filoviruses: One of These Things is (not) Like the Other.丝状病毒：其中之一（并不）与其他的相同。
Viruses. 2015 Sep 29;7(10):5172-90. doi: 10.3390/v7102867.
4
Filovirus vaccines.丝状病毒疫苗
Hum Vaccin. 2011 Jun;7(6):701-11. doi: 10.4161/hv.7.6.15398. Epub 2011 Jun 1.
5
A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.一种单载体、单次注射的三价丝状病毒疫苗：远交豚鼠的概念验证研究
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S384-8. doi: 10.1093/infdis/jiv126. Epub 2015 May 9.
6
Characterization of a putative filovirus vaccine: virus-like particles.一种假定的丝状病毒疫苗的特性：病毒样颗粒。
Virol Sin. 2013 Apr;28(2):65-70. doi: 10.1007/s12250-013-3306-9. Epub 2013 Feb 6.
7
Vaccine research efforts for filoviruses.丝状病毒的疫苗研究工作。
Int J Parasitol. 2003 May;33(5-6):583-95. doi: 10.1016/s0020-7519(03)00064-x.
8
Protection against filovirus infection: virus-like particle vaccines.预防丝状病毒感染：病毒样颗粒疫苗
Expert Rev Vaccines. 2008 Apr;7(3):333-44. doi: 10.1586/14760584.7.3.333.
9
Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.丝状病毒的出现与疫苗研发：旅行医学中医疗从业者的视角。
Travel Med Infect Dis. 2011 May;9(3):126-34. doi: 10.1016/j.tmaid.2010.05.003. Epub 2010 Jun 26.
10
[Innate immunity evasion mechanisms of filoviruses].[丝状病毒的天然免疫逃避机制]
Med Sci (Paris). 2018 Aug-Sep;34(8-9):671-677. doi: 10.1051/medsci/20183408013. Epub 2018 Sep 19.
引用本文的文献
1
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病：全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
2
Bridging Animal and Human Data in Pursuit of Vaccine Licensure.为追求疫苗许可而搭建动物与人类数据的桥梁。
Vaccines (Basel). 2022 Aug 25;10(9):1384. doi: 10.3390/vaccines10091384.
3
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.建立非人灵长类动物对疫苗的反应模型，以确定 SARS-CoV-2 保护的机制相关性。
Elife. 2022 Jul 8;11:e75427. doi: 10.7554/eLife.75427.
4
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.血浆蛋白质组分析区分人类埃博拉病毒病的严重程度结局。
mBio. 2022 Jun 28;13(3):e0056722. doi: 10.1128/mbio.00567-22. Epub 2022 Apr 21.
5
CD47 expression attenuates Ebola virus-induced immunopathology in mice.CD47 表达减弱了埃博拉病毒诱导的小鼠免疫病理。
Antiviral Res. 2022 Jan;197:105226. doi: 10.1016/j.antiviral.2021.105226. Epub 2021 Dec 17.
6
Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages.细胞因子对丝状病毒包膜假型病毒样颗粒进入原代人巨噬细胞的影响。
Viruses. 2019 Sep 23;11(10):889. doi: 10.3390/v11100889.
7
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.一种针对不同丝状病毒种类的预防性多价疫苗具有免疫原性，可保护非人灵长类动物免受埃博拉病毒和马尔堡病毒种类的致死性感染。
PLoS One. 2018 Feb 20;13(2):e0192312. doi: 10.1371/journal.pone.0192312. eCollection 2018.
8
High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test.埃博拉病毒 BSL-4 中和测定法与假型 VSV BSL-2 荧光减少中和试验之间具有高度相关性。
J Virol Methods. 2018 Apr;254:1-7. doi: 10.1016/j.jviromet.2018.01.003. Epub 2018 Jan 31.
9
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.T细胞依赖性机制促进埃博拉病毒样颗粒诱导的抗体反应，但对于疫苗介导的保护作用并非必需。
Emerg Microbes Infect. 2017 Jun 7;6(6):e46. doi: 10.1038/emi.2017.31.
10
Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.预测埃博拉严重程度：埃博拉病毒病的临床优先排序评分
PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005265. doi: 10.1371/journal.pntd.0005265. eCollection 2017 Feb.
本文引用的文献
1
Filoviral immune evasion mechanisms.丝状病毒的免疫逃避机制。
Viruses. 2011 Sep;3(9):1634-49. doi: 10.3390/v3091634. Epub 2011 Sep 7.
2
Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.埃博拉病毒未能刺激浆细胞样树突状细胞产生干扰素反应与其细胞内进入受损有关。
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S973-7. doi: 10.1093/infdis/jir331.
3
Filovirus vaccines.丝状病毒疫苗
Hum Vaccin. 2011 Jun;7(6):701-11. doi: 10.4161/hv.7.6.15398. Epub 2011 Jun 1.
4
Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.马尔堡病毒 VP40 以种属特异性方式拮抗干扰素信号通路。
J Virol. 2011 May;85(9):4309-17. doi: 10.1128/JVI.02575-10. Epub 2011 Feb 16.
5
Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.埃博拉病毒 VP35 抑制常规树突状细胞而非浆细胞样树突状细胞的 IFN 产生。
Immunol Cell Biol. 2011 Oct;89(7):792-802. doi: 10.1038/icb.2010.169. Epub 2011 Jan 25.
6
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.关于丝状病毒科分类的修订提案：分类、分类群名称和病毒名称以及病毒缩写。
Arch Virol. 2010 Dec;155(12):2083-103. doi: 10.1007/s00705-010-0814-x. Epub 2010 Oct 30.
7
Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.人类致命扎伊尔埃博拉病毒感染与异常的先天免疫和大量淋巴细胞凋亡有关。
PLoS Negl Trop Dis. 2010 Oct 5;4(10):e837. doi: 10.1371/journal.pntd.0000837.
8
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.KIR2DS1 和 KIR2DS3 与埃博拉病毒感染的致命结局相关。
Immunogenetics. 2010 Dec;62(11-12):767-71. doi: 10.1007/s00251-010-0480-x. Epub 2010 Sep 29.
9
Advanced antisense therapies for postexposure protection against lethal filovirus infections.针对致命丝状病毒感染的暴露后保护的先进反义疗法。
Nat Med. 2010 Sep;16(9):991-4. doi: 10.1038/nm.2202. Epub 2010 Aug 22.
10
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.载体选择决定了针对安哥拉马尔堡病毒的基因疫苗在非人类灵长类动物中的免疫原性和效力。
J Virol. 2010 Oct;84(19):10386-94. doi: 10.1128/JVI.00594-10. Epub 2010 Jul 21.
Zotero 插件